Published in J Chin Med Assoc on August 21, 2012
Parathyroid conditions in childhood. Semin Pediatr Surg (2014) 0.80
Outcomes of minimally invasive parathyroidectomy in pediatric patients with primary hyperparathyroidism owing to parathyroid adenoma: A single institution experience. J Pediatr Surg (2016) 0.80
A meta-analysis comparing the biochemistry of primary hyperparathyroidism in youths to the biochemistry of primary hyperparathyroidism in adults. J Clin Endocrinol Metab (2014) 0.77
Serum Calcium and Risk of Nonmedullary Thyroid Cancer in Patients with Primary Hyperparathyroidism. Med Sci Monit (2016) 0.75
Endocrine check-up in adolescents and indications for referral: A guide for health care providers. Indian J Endocrinol Metab (2014) 0.75
Bilateral genu valgum: an unusual presentation of juvenile primary hyperparathyroidism. Oxf Med Case Reports (2016) 0.75
Primary hyperparathyroidism masquerading as rickets: diagnostic challenge and treatment outcomes. J Clin Res Pediatr Endocrinol (2013) 0.75
Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients. Endocrinol Diabetes Metab Case Rep (2015) 0.75
The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) (1981) 5.29
Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med (1980) 4.96
Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell (1993) 4.13
A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet (1995) 3.18
Clinical practice. Primary hyperparathyroidism. N Engl J Med (2011) 2.48
Primary hyperparathyroidism in pediatric patients. Pediatrics (2005) 2.35
Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res (2005) 2.15
Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol (2012) 2.14
The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab (2008) 2.12
Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab (1995) 1.79
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. Am J Physiol Renal Physiol (2010) 1.78
Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab (2000) 1.71
The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med (1997) 1.35
Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab (1978) 1.33
The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion. Am J Physiol Endocrinol Metab (2009) 1.32
The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics. Subcell Biochem (2007) 1.23
Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity. J Clin Endocrinol Metab (2010) 1.21
Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention. J Bone Miner Res (1991) 1.13
Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest (1994) 1.13
Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet. J Clin Endocrinol Metab (2011) 1.10
Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Langenbecks Arch Surg (2009) 1.08
The changing presentation of hyperparathyroidism over 3 decades. Arch Surg (2008) 1.07
Solitary parathyroid adenoma: a rare cause of primary hyperparathyroidism in children. Laryngoscope (2007) 1.04
Primary hyperparathyroidism in children and adolescents. Indian J Pediatr (2010) 1.03
Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab (1981) 1.03
Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet (1995) 1.03
Changing biochemical presentation of primary hyperparathyroidism. Langenbecks Arch Surg (2010) 1.01
Clinical profile of primary hyperparathyroidism in adolescents and young adults. Clin Endocrinol (Oxf) (1998) 1.01
Molecular genetics of parathyroid disease. World J Surg (2009) 1.01
What is the optimal treatment for children with primary hyperparathyroidism? J Pediatr Surg (2010) 1.00
Primary hyperparathyroidism in children and adolescents: the Johns Hopkins Children's Center experience 1984-2001. J Bone Miner Res (2002) 0.99
Sporadic primary hyperparathyroidism in young patients: a separate disease entity? Arch Surg (1999) 0.98
Therapeutic radiation and hyperparathyroidism. A case-control study in Rochester, Minn. Arch Intern Med (1989) 0.95
Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr (2004) 0.93
Primary hyperparathyroidism in a paediatric hospital. QJM (1996) 0.93
Primary hyperparathyroidism in neonates and childhood. The French experience (1984-2004). Horm Res (2008) 0.92
Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture. World J Surg (1992) 0.92
A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia. J Clin Endocrinol Metab (2009) 0.91
Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Horm Cancer (2012) 0.91
Characteristics of primary hyperparathyroidism in adolescents. J Pediatr Endocrinol Metab (2008) 0.90
A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia. Clin Endocrinol (Oxf) (2010) 0.90
Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism. J Clin Endocrinol Metab (2000) 0.90
A 10-year retrospective study of primary hyperparathyroidism in children. Exp Clin Endocrinol Diabetes (2012) 0.90
Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) (2011) 0.90
Unusually severe phenotype of neonatal primary hyperparathyroidism due to a heterozygous inactivating mutation in the CASR gene. Eur J Pediatr (2008) 0.89
Primary hyperparathyroidism in childhood and adolescence. J Paediatr Child Health (1996) 0.88
Primary hyperparathyroidism in children. Can J Surg (1982) 0.84
Association of parathyroid adenoma and familial hypocalciuric hypercalcaemia in a teenager. Eur J Endocrinol (2009) 0.84
Familial benign hypercalcaemia: hypercalciuria and hypocalciuria in affected members of a small kindred. Clin Endocrinol (Oxf) (1990) 0.82
Hyperparathyroidism after irradiation for childhood malignancy. Int J Radiat Oncol Biol Phys (2008) 0.80
Primary hyperparathyroidism in children: a review. Mil Med (1983) 0.79
Identification of a novel calcium-sensing receptor gene mutation causing familial hypocalciuric hypercalcemia by single-strand conformation polymorphism analysis. Exp Clin Endocrinol Diabetes (2005) 0.79
Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism. Clin Endocrinol (Oxf) (2002) 0.78
Persistent hypercalcemia after parathyroidectomy in an adolescent and effect of treatment with cinacalcet HCl. Clin Chem (2006) 0.77
Parathyroid adenoma after radiation in an 8-year-old boy. J Pediatr (1998) 0.76
Do calcimimetics directly alter bone remodeling? Am J Physiol Renal Physiol (2010) 0.76
Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med (2002) 3.31
Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A (2004) 2.89
Association between screening for osteoporosis and the incidence of hip fracture. Ann Intern Med (2005) 2.52
Differential susceptibility to hypertension is due to selection during the out-of-Africa expansion. PLoS Genet (2005) 2.33
Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res (2002) 1.84
Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab (2003) 1.72
Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity. J Clin Endocrinol Metab (2006) 1.61
Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet (2002) 1.54
Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. J Biol Chem (2004) 1.47
Expression of GCMB by intrathymic parathyroid hormone-secreting adenomas indicates their parathyroid cell origin. J Clin Endocrinol Metab (2004) 1.46
Cherubism: best clinical practice. Orphanet J Rare Dis (2012) 1.42
Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a. Biochem Biophys Res Commun (2002) 1.36
A mouse model of albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene. Endocrinology (2005) 1.34
Evaluating children with fractures for child physical abuse. Pediatrics (2014) 1.21
A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia. J Bone Joint Surg Am (2005) 1.15
Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1. Am J Hum Genet (2003) 1.11
Hypercalcemia in children and adolescents. Curr Opin Pediatr (2010) 1.09
Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization. J Clin Endocrinol Metab (2014) 1.06
SH3BP2 is an activator of NFAT activity and osteoclastogenesis. Biochem Biophys Res Commun (2008) 1.06
Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation. Hum Mutat (2006) 1.04
Hypocalcemia in the critically ill patient. J Intensive Care Med (2011) 1.03
Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization. Mol Endocrinol (2004) 1.02
Comparison of metabolism of vitamins D2 and D3 in children with nutritional rickets. J Bone Miner Res (2010) 1.02
Consensus development for the supplementation of vitamin D in childhood and adolescence. Horm Res (2002) 1.02
A multinational study to develop universal standardization of whole-body bone density and composition using GE Healthcare Lunar and Hologic DXA systems. J Bone Miner Res (2012) 1.02
Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity. Mol Endocrinol (2003) 1.01
Analysis of the GCM2 gene in isolated hypoparathyroidism: a molecular and biochemical study. J Clin Endocrinol Metab (2008) 1.00
Preimplantation genetic diagnosis for severe albright hereditary osteodystrophy. J Clin Endocrinol Metab (2007) 1.00
Primary hyperparathyroidism in children and adolescents: the Johns Hopkins Children's Center experience 1984-2001. J Bone Miner Res (2002) 0.99
The role of SH3BP2 in the pathophysiology of cherubism. Orphanet J Rare Dis (2012) 0.95
Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation. Mol Endocrinol (2006) 0.95
Molecular pathogenesis of hypophosphatemic rickets. J Clin Endocrinol Metab (2002) 0.94
Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review. J Clin Endocrinol Metab (2013) 0.94
Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone? J Pediatr (2003) 0.93
Reduction in Gsalpha induces osteogenic differentiation in human mesenchymal stem cells. Clin Orthop Relat Res (2005) 0.93
The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene. Cell Cycle (2015) 0.93
Pseudohypoparathyroidism type 1A and morbid obesity in infancy. Endocr Pract (2009) 0.92
A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia. J Clin Endocrinol Metab (2009) 0.91
The pseudohypoparathyroidism type lb locus is linked to a region including GNAS1 at 20q13.3. J Bone Miner Res (2003) 0.91
Decreased expression of the GHRH receptor gene due to a mutation in a Pit-1 binding site. Mol Endocrinol (2002) 0.89
Differential responses of corticotropin-releasing hormone receptor type 1 variants to protein kinase C phosphorylation. J Pharmacol Exp Ther (2006) 0.89
Perinatal calcium metabolism: physiology and pathophysiology. Semin Neonatol (2004) 0.89
Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d. Mol Endocrinol (2008) 0.89
Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter: presentation as hypercalciuria and nephrolithiasis. J Clin Endocrinol Metab (2009) 0.88
Heterotopic ossifications in a mouse model of albright hereditary osteodystrophy. PLoS One (2011) 0.87
Madelung-like deformity in pseudohypoparathyroidism type 1b. J Clin Endocrinol Metab (2011) 0.87
Structural domains determining signalling characteristics of the CRH-receptor type 1 variant R1beta and response to PKC phosphorylation. Cell Signal (2007) 0.87
Vitamin D status in abused and nonabused children younger than 2 years old with fractures. Pediatrics (2011) 0.86
Fibrous dysplasia. Pediatr Endocrinol Rev (2013) 0.85
Laparoscopic versus open radical nephrectomy for xanthogranulomatous pyelonephritis: Contemporary outcomes analysis. J Endourol (2007) 0.85
Prolonged fasting and cortisol reduce myostatin mRNA levels in tilapia larvae; short-term fasting elevates. Am J Physiol Regul Integr Comp Physiol (2002) 0.84
SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism. Clin Orthop Relat Res (2007) 0.84
Clinical management of primary hyperparathyroidism and thresholds for surgical referral: a national study examining concordance between practice patterns and consensus panel recommendations. Endocr Pract (2004) 0.83
Bone mineral density in pseudohypoparathyroidism type 1a. J Clin Endocrinol Metab (2010) 0.82
A novel mutation in the GCM2 gene causing severe congenital isolated hypoparathyroidism. J Pediatr Endocrinol Metab (2012) 0.81
Three novel mutations in the PHEX gene in Chinese subjects with hypophosphatemic rickets extends genotypic variability. Calcif Tissue Int (2011) 0.80
SH3BP2 mutations potentiate osteoclastogenesis via PLCγ. J Orthop Res (2010) 0.80
Mapping structural determinants within third intracellular loop that direct signaling specificity of type 1 corticotropin-releasing hormone receptor. J Biol Chem (2012) 0.80
Genetic and molecular aspects of McCune-Albright syndrome. Pediatr Endocrinol Rev (2007) 0.80
Development of an analytical method for assessment of silver nanoparticle content in biological matrices by inductively coupled plasma mass spectrometry. Biol Trace Elem Res (2014) 0.79
Imprinting status of Galpha(s), NESP55, and XLalphas in cell cultures derived from human embryonic germ cells: GNAS imprinting in human embryonic germ cells. Clin Transl Sci (2009) 0.79
A new missense mutation in the growth hormone-releasing hormone receptor gene in familial isolated GH deficiency. Eur J Endocrinol (2003) 0.79
Decreased SH3BP2 inhibits osteoclast differentiation and function. J Orthop Res (2011) 0.79
Determination of reference intervals for serum total calcium in the vitamin D-replete pediatric population. J Clin Endocrinol Metab (2013) 0.78
Generation of mice encoding a conditional null allele of Gcm2. Transgenic Res (2014) 0.77
A meta-analysis comparing the biochemistry of primary hyperparathyroidism in youths to the biochemistry of primary hyperparathyroidism in adults. J Clin Endocrinol Metab (2014) 0.77
Persistent hypercalcemia after parathyroidectomy in an adolescent and effect of treatment with cinacalcet HCl. Clin Chem (2006) 0.77
Aspects of bioanalytical method validation for the quantitative determination of trace elements. Bioanalysis (2011) 0.77
Comparison of intravenous pamidronate to standard therapy for osteoporosis: use in patients unable to take oral bisphosphonates. J Clin Rheumatol (2005) 0.76
Ketotic hypercalcemia: a case series and description of a novel entity. J Clin Endocrinol Metab (2014) 0.76
Unusual case of hypothyroidism in an infant with hepatic hemangioma. J Pediatr Gastroenterol Nutr (2012) 0.76
Determination of mercury in an assortment of dietary supplements using an inexpensive combustion atomic absorption spectrometry technique. J Autom Methods Manag Chem (2005) 0.76
Cloning and characterization of the human SH3BP2 promoter. Biochem Biophys Res Commun (2012) 0.75
Premature Epiphyseal Closure of the Lower Extremities Contributing to Short Stature after cis-Retinoic Acid Therapy in Medulloblastoma: A Case Report. Horm Res Paediatr (2015) 0.75
Transmission imaging for integrated PET-MR systems. Phys Med Biol (2016) 0.75
Current therapy for childhood thyroid cancer: optimal surgery and the legacy of king pyrrhus. Ann Surg Oncol (2003) 0.75
A novel intronic mutation in SHOX causes short stature by disrupting a splice acceptor site: direct demonstration of aberrant splicing by expression of a minigene in HEK-293T cells. J Pediatr Endocrinol Metab (2012) 0.75
50 years ago in the Journal of Pediatrics: metabolic studies in a patient with idiopathic hypercalcemia of infancy. J Pediatr (2013) 0.75
Asthma, allergy, and airway hyperresponsiveness are not linked to the beta(2)-adrenoceptor gene. Chest (2002) 0.75